BackAN2 Therapeutics Overview

AN2 Therapeutics Total Assets

Latest total assets for ANTX: $87M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$87.49M
↑ 7.56% YoYΔ $6.15M vs prior year quarter

Peer average

Loading

AN2 Therapeutics Total Assets History

Loading

AN2 Therapeutics vs. peers: Total Assets Comparison

Loading

AN2 Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AN2 Therapeutics (ANTX) FAQ

As of the most recent data (March 2026), ANTX shows a total assets of $87M. That compares with $81M in the prior-year period — up 7.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANTX's total assets is now $87M (was $81M) — a 7.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether AN2 Therapeutics is outperforming or lagging.

Tracking ANTX's total assets over time shows whether AN2 Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $87M That compares with $81M in the prior-year period — up 7.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has AN2 Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $87M) with ownership activity and broader fundamentals.